ARCHIMED
Ian MacGregor is an accomplished finance professional with extensive experience in investor relations and capital advisory. Currently serving as Associate Director of Investor Relations & Co-Investment at ARCHIMED since July 2022, Ian previously held managerial and associate roles at notable institutions including Vista Equity Partners, Greenhill & Co., and MHT Partners. Notably, in the role of Senior Investment Associate at Cambridge Associates, Ian focused on sourcing and monitoring private equity fund investments for a global institutional clientele. Ian holds an MBA from the Texas McCombs School of Business and a Bachelor of Arts in Philosophy from Trinity College-Hartford.
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.